S. Brienza

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

Sylvie Giacchetti, M. Itzhaki, G. Gruia et al. · Annals of Oncology · 1999 · 607 citations

Medicine, Oncology, Surgery +16

Clinical pharmacokinetics of oxaliplatin: a critical review.

Martin A. Graham, G. Lockwood, Dennis Greenslade et al. · PubMed · 2000 · 461 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +15

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont et al. · Annals of Oncology · 1996 · 434 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

Françis Lévi, Jean-Louis Misset, S. Brienza et al. · Cancer · 1992 · 338 citations

Medicine, Oncology, Pharmacology +17

Phase I Trial of 5-Day Continuous Venous Infusion of Oxaliplatin at Circadian Rhythm-Modulated Rate Compared With Constant Rate

J. P. Caussanel, Francis Lévi, S. Brienza et al. · JNCI Journal of the National Cancer Institute · 1990 · 252 citations

Medicine, Oncology, Pharmacology +17